Comparison of the Safety and Efficacy of Ophtesis Bio 3% With a Similar 3% Sodium Hyaluronate OVD

Inclusion Criteria: * Cataract for which extraction and posterior intraocular lens (IOL) implantation have been planned for one or both eyes * Clear intraocular media, other than cataract * Availability, willingness and sufficient cognitive awareness to comply with examination procedures * Signed informed consent Exclusion Criteria: * Pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils) * Recent ocular trauma or ocular surgery that is not resolved/stable or may affect visual outcomes or increase risk to the subject * Use of systemic or ocular medications that may affect IOP * Known steroid responder * Ocular hypertension of ≥ 20 mmHg, medically-controlled ocular hypertension (regardless of IOP value), or glaucomatous changes in the optic nerve * Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes * Concurrent participation or participation within 45 days prior to preoperative visit in any other clinical trial